Cargando…
Discovery of New Chemical Tools against Leishmania amazonensis via the MMV Pathogen Box
The protozoan parasite Leishmania causes a spectrum of diseases and there are over 1 million infections each year. Current treatments are toxic, expensive, and difficult to administer, and resistance to them is emerging. In this study, we screened the antileishmanial activity of the Pathogen Box com...
Autores principales: | López-Arencibia, Atteneri, Sifaoui, Ines, Reyes-Batlle, María, Bethencourt-Estrella, Carlos J., San Nicolás-Hernández, Desirée, Lorenzo-Morales, Jacob, Piñero, José E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708704/ https://www.ncbi.nlm.nih.gov/pubmed/34959620 http://dx.doi.org/10.3390/ph14121219 |
Ejemplares similares
-
In vitro activity of 1H-phenalen-1-one derivatives against Leishmania spp. and evidence of programmed cell death
por: López-Arencibia, Atteneri, et al.
Publicado: (2019) -
Selective activity of Oleanolic and Maslinic Acids on the Amastigote form of Leishmania Spp
por: Sifaoui, Ines, et al.
Publicado: (2017) -
Acrylonitrile Derivatives against Trypanosoma cruzi: In Vitro Activity and Programmed Cell Death Study
por: Bethencourt-Estrella, Carlos J., et al.
Publicado: (2021) -
Withanolides from Withania aristata as Antikinetoplastid Agents through Induction of Programmed Cell Death
por: López-Arencibia, Atteneri, et al.
Publicado: (2019) -
Laurequinone, a Lead Compound against Leishmania
por: García-Davis, Sara, et al.
Publicado: (2023)